Literature DB >> 19367689

Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium.

Sergio Pecorelli1.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19367689     DOI： 10.1016/j.ijgo.2009.02.012

Source DB:  PubMed          Journal:  Int J Gynaecol Obstet        ISSN： 0020-7292            Impact factor:   3.561


× No keyword cloud information.
  648 in total

1.  Current status in the management of uterine corpus cancer in Korea.

Authors:  Nan-Hee Jeong; Jong-Min Lee; Seon-Kyung Lee
Journal:  J Gynecol Oncol       Date:  2010-09-28       Impact factor: 4.401

2.  Rate of port-site metastasis is uncommon in patients undergoing robotic surgery for gynecological malignancies.

Authors:  Bih T Ndofor; Pamela T Soliman; Kathleen M Schmeler; Alpa M Nick; Michael Frumovitz; Pedro T Ramirez
Journal:  Int J Gynecol Cancer       Date:  2011-07       Impact factor: 3.437

3.  Prognostic significance of SUVmax (maximum standardized uptake value) measured by [¹⁸F]FDG PET/CT in endometrial cancer.

Authors:  Kazuhiro Kitajima; Masato Kita; Kayo Suzuki; Michio Senda; Yuji Nakamoto; Kazuro Sugimura
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-02-17       Impact factor: 9.236

4.  Staging of uterine cervical cancer with MRI: guidelines of the European Society of Urogenital Radiology.

Authors:  Corinne Balleyguier; E Sala; T Da Cunha; A Bergman; B Brkljacic; F Danza; R Forstner; B Hamm; R Kubik-Huch; C Lopez; R Manfredi; J McHugo; L Oleaga; K Togashi; K Kinkel
Journal:  Eur Radiol       Date:  2010-11-10       Impact factor: 5.315

5.  Advances in magnetic resonance imaging of endometrial cancer.

Authors:  Evis Sala; Andrea Rockall; Rahel A Kubik-Huch
Journal:  Eur Radiol       Date:  2010-11-27       Impact factor: 5.315

6.  Granulosa Cell Tumors: Novel Predictors of Recurrence in Early-stage Patients.

Authors:  Sharif Sakr; Eman Abdulfatah; Sumi Thomas; Zaid Al-Wahab; Rafic Beydoun; Robert Morris; Rouba Ali-Fehmi; Sudeshna Bandyopadhyay
Journal:  Int J Gynecol Pathol       Date:  2017-05       Impact factor: 2.762

Review 7.  Medical Device Safety and Surgical Dissemination of Unrecognized Uterine Malignancy: Morcellation in Minimally Invasive Gynecologic Surgery.

Authors:  Tracilyn Hall; Susanna I Lee; David M Boruta; Annekathryn Goodman
Journal:  Oncologist       Date:  2015-09-17

8.  Brachytherapy for cervical cancer in septate uterus: Dose-volume differences with tandem implant placement in right vs. left uterine canal: A case report.

Authors:  Naoya Ishibashi; Toshiya Maebayashi; Takuya Aizawa; Masakuni Sakaguchi; Takehiro Nakao; Masahiro Okada
Journal:  Oncol Lett       Date:  2018-03-06       Impact factor: 2.967

9.  XPA expression is a predictive marker of the effectiveness of neoadjuvant chemotherapy for locally advanced uterine cervical cancer.

Authors:  Takuma Wada; Takeshi Fukuda; Masahiro Shimomura; Yuta Inoue; Masaru Kawanishi; Reiko Tasaka; Tomoyo Yasui; Kazuo Ikeda; Toshiyuki Sumi
Journal:  Oncol Lett       Date:  2018-01-16       Impact factor: 2.967

10.  Efficacy of contemporary chemotherapy in stage IIIC endometrial cancer: a histologic dichotomy.

Authors:  Jamie N Bakkum-Gamez; Andrea Mariani; Sean C Dowdy; Amy L Weaver; Michaela E McGree; Janice R Martin; Gary L Keeney; Aminah Jatoi; Bobbie S Gostout; Karl C Podratz
Journal:  Gynecol Oncol       Date:  2014-01-14       Impact factor: 5.482
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.